Recombinant HuD/ELAVL4 E Neoantigen

Recombinant HuD E/ELAVL4 neoantigen expressed in E. coli and purified via affinity chromatography.

Highlights:

  • HuD E is a mutant derivative of HuD which is expressed in melanoma and SCLC tumor cells
  • Can be used to detect the presence of tumor antibodies which may be uesfull in the detection of a tumor or its response to immunotherapy

ELAV-like protein 4 (ELAVL4, HuD) plays a role in neuron-specific RNA processing and protects CDKN1A mRNA from decay by binding to its 3'-UTR (By similarity). HuD binds to AU-rich sequences (AREs) of target mRNAs, including VEGF and FOS mRNA. HuD was originaly discovered as the paraneoplastic antigen expressed in neuroendocrine tumors. Recombinant HuD was first used to assay the presence of anti-Hu antibodies and thereby diagnose the presence of small cell lung cancer and subacute sensory neuronopathy. In normal cells , it functions to regulate gene expression and the recombinant protein has been used to identify regualtory elements in mRNA.

Catalog Number Product DataSheet Size AVAILABILITY Price Qty
FCG005
Recombinant HuD/ELAVL4 E Neoantigen
10ug In stock
Regular Price:$475.00
On Sale:
Specifications

Product Type: Protein
Name: Recombinant HuD E Protein
Accession ID: P26378
Source: Recombinant from E. coli
Format: Liquid
Buffer: PBS, pH 7.2
Tested Applications: Detection of anti-Tumor antibodies via WB or ELISA assay
Storage: -20C
Shipped: Ambient temp. Upon delivery, aliquot and store at 4C (short term) or -20C (long term).

Data

SDS-PAGE Analysis

SDS Gel analysis of recombinant HuD E.

References

If you publish research with this product, please let us know so we can cite your paper.

Loading...